While eye drops can help with diabetes-related symptoms, such as dry eyes or irritation, they do not treat the underlying retinopathy. Diabetic retinopathy is a diabetes-related complication that ...

Sterling Glass had many health problems as a child—swollen feet, night sweats, nausea and vomiting, unquenchable thirst, and ...

People with diabetic macular edema may get eye injections to help control their symptoms. These eye injections can improve vision and also stop the damage that causes vision to get worse. Most of ...

People with diabetic macular edema may receive eye injections to help control their symptoms. These shots can help to improve vision and also stop the damage that causes vision issues to get worse.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today two-year data from the Phase III Pagoda and Pavilion studies ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

Susvimo was nonferior to intravitreal ranibizumab based on the change from baseline in distance best corrected visual acuity score. The Food and Drug Administration (FDA) has approved Susvimo ® ...

Intravitreal RPCs showed positive effects on electroretinography, optomotor response, and contrast sensitivity in a rat model ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo ...

Diabetic eye disease doesn’t announce itself loudly. It often creeps in gradually, unnoticed until vision begins to blur or dim. For many, these changes may feel sudden, but they are in fact the ...

While eye drops may help alleviate some symptoms of diabetic retinopathy, they don’t target the underlying blood vessel damage in your retina. Retinopathy is a possible complication of diabetes. At ...